Oral Therapy for RRMS in a Nutshell: Tecfidera Recent Findings

news_15_Artboard 343 copy 250

Tecfidera is an oral medication that researchers believe effectively inhibits immune system cells and molecules and acts as an anti-oxidant that potentially protects against demyelination and the loss of neurons that occurs in Multiple Sclerosis (MS).

Learn more about Tecfidera here.

Throughout the years, and since its FDA approval, Tecfidera has emerged as a first-line treatment for relapsing-remitting multiple sclerosis (RRMS), the most common form of MS.

Learn more about the recent clinical trials that studied Tecfidera and its role in treating RRMS.

Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

One comment

  1. Linda Neal says:

    I took it for over a year and it destroyed my teeth. They came out in chunks. I will have to have whatever is left completely removed, let it heal hopefully taking only three months before everything is going to be totally replaced. The last estimate a year ago was $22,000. I don’t know when I will be able to get the work done but by that point I am sure it will be much more.

Leave a Comment

Your email address will not be published. Required fields are marked *